This site is intended for healthcare professionals
News

European Patent Office rules in favor of Sanofi and Regeneron concerning Praluent.

Read time: 1 mins
Last updated:30th Oct 2020
Published:30th Oct 2020
Condition: Dyslipidaemia
Type: drug
Register free for full access to medthority.com